What COVID-19 can do to the brain:
Studie afslører en ny senfølge (BT.dk, Jan 19, 2024)
The COVID-19 virus can infect dopamine neurons in the brain and make cells lose the ability to grow. The finding may shed light on neurological symptoms of COVID, like brain fog, according to a team led by Dr. Shuibing Chen (@ChenShuibing) of @WCMSurgery.
https://bit.ly/47yH69n
Weill Cornell Medicine (X, Jan 17, 2024)
A new study reported that SARS-CoV-2, the virus that causes COVID, can infect dopamine neurons in the brain and trigger senescence—when a cell loses the ability to grow and divide. The researchers from Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and Columbia University Vagelos College of Physicians and Surgeons suggest that further research on this finding may shed light on the neurological symptoms associated with long COVID such as brain fog, lethargy and depression.
The findings, published in Cell Stem Cell on Jan. 17, show that dopamine neurons infected with SARS-CoV-2 stop working and send out chemical signals that cause inflammation. Normally, these neurons produce dopamine, a neurotransmitter that plays a role in feelings of pleasure, motivation, memory, sleep and movement. Damage to these neurons is also connected to Parkinson’s disease.
SARS-CoV-2 Can Infect Dopamine Neurons Causing Senescence (Weill Cornell Medicine, Jan 17, 2024)
Highlights
• hPSC-derived DA neurons are susceptible to SARS-CoV-2 infection
• SARS-CoV-2 infection of DA neurons triggers cellular senescence response
• Several FDA-approved drugs were identified to rescue senescence of DA neurons
• Cellular senescence was found in substantia nigra tissues of COVID-19 patients
Summary
COVID-19 patients commonly present with signs of central nervous system and/or peripheral nervous system dysfunction. Here, we show that midbrain dopamine (DA) neurons derived from human pluripotent stem cells (hPSCs) are selectively susceptible and permissive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
SARS-CoV-2 infection of DA neurons triggers an inflammatory and cellular senescence response. High-throughput screening in hPSC-derived DA neurons identified several FDA-approved drugs that can rescue the cellular senescence phenotype by preventing SARS-CoV-2 infection. We also identified the inflammatory and cellular senescence signature and low levels of SARS-CoV-2 transcripts in human substantia nigra tissue of COVID-19 patients. Furthermore, we observed reduced numbers of neuromelanin+ and tyrosine-hydroxylase (TH)+ DA neurons and fibers in a cohort of severe COVID-19 patients.
Our findings demonstrate that hPSC-derived DA neurons are susceptible to SARS-CoV-2, identify candidate neuroprotective drugs for COVID-19 patients, and suggest the need for careful, long-term monitoring of neurological problems in COVID-19 patients.
SARS-CoV-2 infection causes dopaminergic neuron senescence (Cell, Jan 17, 2024)
Studie afslører en ny senfølge (BT.dk, Jan 19, 2024)


